
Meet Zenovel at CPHI Milan 2026: Let’s Discuss Your GxP Compliance & Clinical Research Needs
The global pharmaceutical industry will convene in Milan for CPHI Milan 2026 from 6–8 October 2026 at Fiera Milano, Italy,
We Embody a Legacy of Incredible Discoveries, Exploring the Boundaries of Innovation and Science

At Zenovel, we integrate our extensive expertise across a wide range of domains, from Good Clinical Practice to Regulatory Affairs, to present valuable insights and thought leadership. Each blog reflects our intense dedication to innovation, offering a forum to share our perspectives, groundbreaking ideas, and industry expertise. Through our blogs, we hope to uplift, inform, and support scientific, medical, and pharmaceutical innovation.

The global pharmaceutical industry will convene in Milan for CPHI Milan 2026 from 6–8 October 2026 at Fiera Milano, Italy,

Bioequivalence (BE) studies are essential for generic drug development, demonstrating that generics deliver the same active ingredients as brand-name drugs.

The generic pharmaceutical industry is at a critical juncture. Traditionally, the route to market for generics involved proving bioequivalence via

The global generic pharmaceutical industry plays a crucial role in healthcare, comprising over 90% of prescriptions in the U.S. and

The oral solid dosage (OSD) forms—tablets, capsules, and granules—are essential to the global pharmaceutical market, dominating prescriptions due to their

In 2026, the US FDA’s approach to GMP inspections has drastically changed for pharmaceutical manufacturers in Bangalore. The agency is

For manufacturers of tablets and capsules, effective regulatory writing is essential for navigating the complex process from formulation to market

For pharmaceutical companies aiming for US FDA approval, a regulatory dossier is crucial, serving as the scientific and legal basis

The pharmaceutical industry is rapidly transforming, with manufacturers of tablets and capsules, especially in India, expanding their global presence and

India’s clinical research landscape has transformed from a low-cost trial destination to a quality-focused R&D ecosystem, with the market valued

The global clinical research landscape is transforming, with sponsors, CROs, and research organizations adapting to evolving regulations and decentralized technologies

In today’s highly regulated pharmaceutical industry, Good Manufacturing Practice (GMP) compliance is more than a regulatory requirement—it’s a critical factor

In clinical research, Glucagon-like peptide-1 (GLP-1) receptor agonists have gained significant attention for their transformative effects in diabetes treatment and

In the regulated life sciences industry, Contract Research Organizations (CROs) are crucial for advancing drug development and clinical trials. The

India is increasingly recognized as an attractive site for global clinical research due to its large patient population, skilled investigators,
We provide affordable, innovative, and high-quality solutions to pharma industry with ethics driven research and increasing accessibility to high quality medicine worldwide
Write to us : bd@zenovel.com
Copyright © 2026 Zenovel. All rights reserved.